OMA Guidelines Bundle

Obesity-Related Diseases 2026

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1544298

Contents of this Issue

Navigation

Page 20 of 45

21   ➤ Classifying HF by LVEF • HF is categorized based on LVEF and clinical stage. HFrEF is defined by LVEF ≤40%; HF with improved EF refers to patients with prior LVEF ≤40% and subsequent improvement to >40%; HF with mildly reduced EF (HFmrEF) is characterized by LVEF 41% to 49%. HFpEF is defined by LVEF ≥50% with evidence of elevated or inducible left ventricular filling pressures (increased natriuretic peptides or abnormal hemodynamics). Staging of HF progresses from:   ▶ Stage A: individuals at risk without symptoms or cardiac abnormalities.   ▶ Stage B (pre-HF): structural heart changes or persistently elevated biomarkers without symptoms.   ▶ Stage C: structural heart disease with current or prior symptoms.   ▶ Stage D: ref ractory, advanced HF with severe symptoms and repeated hospitalizations despite optimal management.

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity-Related Diseases 2026